4
Changes in Ownership
ANAPTYSBIO, INC Filed Acc 0001415889-24-023550
Chief Medical Officer sold 2,220 shares at $38.93 ($86,425)
- Chief Medical Officer acquired 6,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Lizzul Paul F. · Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-09-14 | Exercise or conversion : show line 1 in the form 10b5-1 | +6,000 | 17,618 | D | ||
| 2024-09-16 | Sale : show line 2 in the form 10b5-1 | −2,220 | $38.93 | $86,425 | 15,398 | D |
| Open-market sales · 2,220 sh · avg $38.93 · $86,425 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-09-14 | Exercise or conversion : show line 3 in the form 10b5-1 Restricted Stock Unit | −6,000 | 0 | D |
Loading xslF345X05/form4-09172024_100907.xml…